Clinical Trial Detail

NCT ID NCT02644291
Title Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

brain cancer

medulloblastoma

malignant glioma

Therapies

Mebendazole

Age Groups: child adult

No variant requirements are available.